ArticleParasites & vectors2026
Comparative proteomic analysis of the angiogenic response in an in vitro model of vascular endothelial cells to excretory/secretory and somatic antigens of Dirofilaria immitis.
Article in Parasites & vectors, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDirofilaria immitis infection induces endothelial inflammation and vascular remodeling, contributing to heartworm disease pathology. While excretory/secretory antigens (DiES) are known to promote angiogenesis, somatic antigens (DiSA) exhibit different modulatory effects. This study aims to characterize the differential angiogenic response of endothelial cells to these antigenic fractions using a proteomic approach.
methodsHuman umbilical vein endothelial cells were cultured and stimulated for 24 h with DiES or DiSA, either alone or supplemented with vascular endothelial growth factor (VEGF)-A to simulate active angiogenesis. Proteomic profiles of cell supernatants and lysates were analyzed using data-independent acquisition-label-free quantification (DIA-LFQ) liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). Bioinformatic analyses, including Gene Ontology and pathway enrichment, were performed to identify dysregulated proteins and molecular mechanisms related to angiogenesis.
resultsStimulation with DiES, particularly in combination with VEGF-A, produced the most significant enrichment of angiogenic processes, characterized by the downregulated anti-angiogenic proteins tryptophanyl-tRNA synthetase 1 (WARS1) and the modulation of the phosphatidylinositol-3 kinase (PI3K)/protein kinase B (AKT) pathway [upregulated 3-phosphoinositide-dependent protein kinase 1 (PDPK1) and downregulated AKT3]. Conversely, DiSA induced a limited angiogenic response with fewer dysregulated proteins. Notably, angiopoietin-2 (ANGPT2) was upregulated in all treatments, suggesting universal vascular destabilization. However, in the absence of VEGF-A, both antigens induced markers of vascular regression and cell lysis.
conclusionsDiSA and DiES exert distinct immunomodulatory effects on the endothelium. DiES acts synergistically with VEGF-A to drive angiogenesis via the ANGPT/tyrosine kinase receptor (TIE) and PI3K/AKT axes, whereas DiSA fails to support this process effectively. These proteomic insights contribute to elucidate the molecular mechanisms driving vascular remodeling and pathology in heartworm disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.